litlas
Log inCreate account

Daniel Rachmilewitz

Active 1971–2016

39
Papers
24,018
Citations
39
h-index
39
i10-index

Citations

Citations per year for Daniel Rachmilewitz1973: 6 citations1974: 2 citations1975: 10 citations1976: 6 citations1977: 9 citations1978: 10 citations1979: 9 citations1980: 18 citations1981: 9 citations1982: 14 citations1983: 17 citations1984: 19 citations1985: 16 citations1986: 9 citations1987: 20 citations1988: 16 citations1989: 6 citations1990: 28 citations1991: 28 citations1992: 29 citations1993: 25 citations1994: 19 citations1995: 45 citations1996: 36 citations1997: 38 citations1998: 57 citations1999: 39 citations2000: 48 citations2001: 49 citations2002: 71 citations2003: 100 citations2004: 156 citations2005: 243 citations2006: 275 citations2007: 309 citations2008: 239 citations2009: 216 citations2010: 263 citations2011: 270 citations2012: 225 citations2013: 273 citations2014: 233 citations2015: 244 citations2016: 180 citations2017: 192 citations2018: 187 citations2019: 597 citations2020: 487 citations2021: 388 citations2022: 315 citations2023: 251 citations2024: 366 citations2025: 152 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,858 citing papers, 22% of this breakdownUnited Kingdom: 646 citing papers, 7.6% of this breakdownCanada: 586 citing papers, 6.9% of this breakdownGermany: 515 citing papers, 6.1% of this breakdownItaly: 506 citing papers, 6% of this breakdownFrance: 473 citing papers, 5.6% of this breakdownChina: 360 citing papers, 4.3% of this breakdownBelgium: 352 citing papers, 4.2% of this breakdownNetherlands: 328 citing papers, 3.9% of this breakdownJapan: 298 citing papers, 3.5% of this breakdownSpain: 261 citing papers, 3.1% of this breakdownAustralia: 210 citing papers, 2.5% of this breakdown
0%22%Other 24.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology61.2%
  • Medicine24%
  • Immunology and Microbiology7.4%
  • Agricultural and Biological Sciences2.8%
  • Nursing1.6%
  • Neuroscience1.4%
  • Other1.6%

Topics

  • Inflammatory Bowel Disease21.6%
  • Microscopic Colitis8.2%
  • Rheumatoid Arthritis Research and Therapies4.1%
  • Autoimmune and Inflammatory Disorders4%
  • Gut microbiota and health3.9%
  • Biosimilars and Bioanalytical Methods2.8%
  • Other55.4%

Coauthors

All papers

Open in search
  1. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

    Authors: Paul Rutgeerts, William J. Sandborn, Brian G. Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B. Hanauer, Gary R. Lichtenstein, Willem J.S. de Villiers, Daniel H. Present, Bruce E. Sands, Jean‐Frédéric Colombel - New England Journal of Medicine 2005 cited by 3,883

  2. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

    Authors: Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch, Gerassimos J. Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D’Haens, Robert H. Diamond, Delma L. Broussard, Kezhen L. Tang, C. Janneke van der Woude, Paul Rutgeerts - New England Journal of Medicine 2010 cited by 3,108

  3. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    Authors: Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein, Lloyd Mayer, Stefan Schreiber, Jean‐Frédéric Colombel, Daniel Rachmilewitz, Douglas C. Wolf, Allan Olson, Weihang Bao, Paul Rutgeerts - The Lancet 2002 cited by 4,163

  4. Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

    Authors: Bruce E. Sands, Frank Anderson, Çharles N. Bernstein, William Y. Chey, Brian G. Feagan, Richard N. Fedorak, Michael A. Kamm, Joshua R. Korzenik, Bret A. Lashner, Jane E. Onken, Daniel Rachmilewitz, Paul Rutgeerts, Gary Wild, Douglas C. Wolf, P Marsters, Suzanne Travers, Marion Blank, S J van Deventer - New England Journal of Medicine 2004 cited by 2,221

  5. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

    Authors: Miguel Regueiro, Brian G. Feagan, Bin Zou, Jewel Johanns, Marion Blank, Marc Chévrier, Scott E. Plevy, John Popp, Freddy Cornillie, Milan Lukáš, Silvio Danese, Paolo Gionchetti, Stephen B. Hanauer, Walter Reinisch, William J. Sandborn, Dario Sorrentino, Paul Rutgeerts, Henry Debinski, Tim Florin, David J. Hetzel, Ian C. Lawrance, G. Radford‐Smith, Andrew Sloss, Dario Sorrentino, S Gassner, T Haas, G Reicht, Walter Reinisch, Michael Straßer, Harald Vogelsang, Peter Bossuyt, Olivier Dewit, Geert D’Haens, Denis Franchimont, Édouard Louis, Séverine Vermeire, Çharles N. Bernstein, Raymond Bourdages, Naoki Chiba, Sonny S. Dhalla, Brian G. Feagan, Richard N. Fedorak, Jean-René Lachance, Remo Panaccione, Mark J. Ropeleski, B Salh, M Lukas, J.F. Colombel, Matthieu Allez, Pierre Desreumaux, Jean Louis Dupas, J.C. Grimaud, Xavier Hébuterne, David Laharie, Éric Lerebours, Laurent Peyrin‐Biroulet, J.M. Reimund, Stéphanie Viennot, Frank Zerbib, Castells Antoni, Raja Atreya, Daniel C. Baumgart, Christoph Berg, Ulrich Boecker, G. Bramkamp, C. Bünning, Robert Ehehalt, S Howaldt, Torsten Kucharzik, Hein Lamprecht, Jonas Mudter, J. Preiß, Stefan Schreiber, Ursula Seidler, I Altorjay, János Banai, Péter L. Lakatos, Márta Varga, Áron Vincze, Irit Avni‐Biron, Sigal Fishman, Gerald Fraser, Ehud Goldin, Daniel Rachmilewitz, Vito Annese, Sandro Ardizzone, Livia Biancone, Fabrizio Bossa, Silvio Danese, Walter Fries, Paolo Gionchetti, Giovanni Maconi, Giovanni Terrosu, P. Usai, Geert D’Haens, Richard B. Gearry, Jeffrey Hill, David Rowbotham, Michael Schultz, R.S. Stubbs and 56 more - Gastroenterology 2016 cited by 329

  6. Toll-like receptor 9–induced type I IFN protects mice from experimental colitis

    Authors: Kyoko Katakura, Jong‐Dae Lee, Daniel Rachmilewitz, Gloria Li, Lars Eckmann, Eyal Raz - Journal of Clinical Investigation 2005 cited by 448

  7. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis

    Authors: Daniel Rachmilewitz, Fanny Karmeli, Kenji Takabayashi, Tomoko Hayashi, Leonor Leider–Trejo, Jong‐Dae Lee, Lorenzo M. Leoni, Eyal Raz - Gastroenterology 2002 cited by 388

  8. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis

    Authors: Daniel Rachmilewitz, Kyoko Katakura, Fanny Karmeli, Tomoko Hayashi, Constantin Reinus, Bernard Rudensky, Shizuo Akira, Kiyoshi Takeda, Jong‐Dae Lee, Kenji Takabayashi, Eyal Raz - Gastroenterology 2004 cited by 858

  9. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease

    Authors: Paul Rutgeerts, Brian G. Feagan, Gary R. Lichtenstein, Lloyd Mayer, Stefan Schreiber, Jean‐Frédéric Colombel, Daniel Rachmilewitz, Douglas C. Wolf, Allan Olson, Weihang Bao, Stephen B. Hanauer - Gastroenterology 2004 cited by 948

  10. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

    Authors: Daniel Rachmilewitz - BMJ 1989 cited by 1,045

  11. Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

    Authors: Marc Ferrante, Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch, Gerassimos J. Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D’Haens, C. Janneke van der Woude, Silvio Danese, Robert H. Diamond, Alessandra Oortwijn, Kezhen L. Tang, Michael Craig Miller, Freddy Cornillie, Paul Rutgeerts - Gastroenterology 2013 cited by 178

  12. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease.

    Authors: M. Ligumsky, P L Simon, Fanny Karmeli, Daniel Rachmilewitz - Gut 1990 cited by 406

  13. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

    Authors: Daniel Rachmilewitz, Jonathan S. Stamler, Dale R. Bachwich, Fanny Karmeli, Zvi Ackerman, Daniel K. Podolsky - Gut 1995 cited by 373

  14. A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

    Authors: Christoph Gasché, Jürgen Schölmerich, Jørn Brynskov, Geert D’Haens, Stephen B. Hanauer, Jan E. Irvine, Derek P. Jewell, Daniel Rachmilewitz, David B. Sachar, William J. Sandborn, Lloyd R. Sutherland - Inflammatory Bowel Diseases 2000 cited by 1,140

  15. Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies

    Authors: Walter Reinisch, William J. Sandborn, Paul Rutgeerts, Brian G. Feagan, Daniel Rachmilewitz, Stephen B. Hanauer, Gary R. Lichtenstein, Willem J.S. de Villiers, Marion Blank, Yinghua Lang, Jewel Johanns, Jean‐Frédéric Colombel, Daniel H. Present, Bruce E. Sands - Inflammatory Bowel Diseases 2011 cited by 208

  16. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones

    Authors: Rivka Dresner–Pollak, Nir Gelb, Daniel Rachmilewitz, Fanny Karmeli, Miron Weinreb - Gastroenterology 2004 cited by 166

  17. Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

    Authors: William J. Sandborn, Paul Rutgeerts, Brian G. Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Jiandong Lu, Kevin Horgan, Daniel Rachmilewitz, Stephen B. Hanauer, Gary R. Lichtenstein, Willem J.S. de Villiers, Daniel H. Present, Bruce E. Sands, Jean‐Frédéric Colombel - Gastroenterology 2009 cited by 472

  18. Role of Prostaglandins in Ulcerative Colitis

    Authors: P. Sharon, M. Ligumsky, Daniel Rachmilewitz, U. Zor - Gastroenterology 1978 cited by 392

  19. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

    Authors: P. Sharon, M. Ligumsky, Daniel Rachmilewitz, U. Zor - 1978 cited by 454

  20. Probiotics in inflammatory bowel disease: possible mechanisms of action.

    Authors: Iris Dotan, Daniel Rachmilewitz - 2005 cited by 120

  21. Peroxynitrite-induced rat colitis—A new model of colonic inflammation

    Authors: Daniel Rachmilewitz, Jonathan S. Stamler, Fanny Karmeli, Mark E. Mullins, David J. Singel, J Loscalzo, Ramnik J. Xavier, Daniel K. Podolsky - Gastroenterology 1993 cited by 264

  22. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine

    Authors: M. Ligumsky, Fanny Karmeli, Pinchas Sharon, U. Zor, F Cohen, Daniel Rachmilewitz - Gastroenterology 1981 cited by 223

  23. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells

    Authors: Kenneth R. Youngman, P L Simon, Gail West, Fabio Cominelli, Daniel Rachmilewitz, John S. Klein, Claudio Fiocchi - Gastroenterology 1993 cited by 199

  24. Role of platelet-activating factor in ulcerative colitis

    Authors: Rami Eliakim, Fanny Karmeli, Ehud Razin, Daniel Rachmilewitz - Gastroenterology 1988 cited by 197